Sanofi/€SAN
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Sanofi
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Ticker
€SAN
Sector
Primary listing
PAR
Employees
82,878
Headquarters
Website
Sanofi Metrics
BasicAdvanced
€103B
11.46
€7.36
0.41
€3.92
4.65%
Price and volume
Market cap
€103B
Beta
0.41
52-week high
€110.88
52-week low
€77.88
Average daily volume
13K
Dividend rate
€3.92
Financial strength
Current ratio
1.274
Quick ratio
0.811
Long term debt to equity
20.951
Total debt to equity
31.709
Dividend payout ratio (TTM)
52.29%
Interest coverage (TTM)
16.91%
Profitability
EBITDA (TTM)
12,082
Gross margin (TTM)
71.32%
Net profit margin (TTM)
19.95%
Operating margin (TTM)
20.51%
Effective tax rate (TTM)
19.24%
Revenue per employee (TTM)
€550,000
Management effectiveness
Return on assets (TTM)
4.65%
Return on equity (TTM)
9.00%
Valuation
Price to earnings (TTM)
11.459
Price to revenue (TTM)
2.286
Price to book
1.47
Price to tangible book (TTM)
5.94
Price to free cash flow (TTM)
12.445
Free cash flow yield (TTM)
8.04%
Free cash flow per share (TTM)
6.78
Dividend yield (TTM)
4.65%
Forward dividend yield
4.65%
Growth
Revenue change (TTM)
15.65%
Earnings per share change (TTM)
117.96%
3-year revenue growth (CAGR)
2.85%
10-year revenue growth (CAGR)
3.35%
3-year earnings per share growth (CAGR)
11.55%
10-year earnings per share growth (CAGR)
7.20%
3-year dividend per share growth (CAGR)
5.59%
10-year dividend per share growth (CAGR)
3.24%
What the Analysts think about Sanofi
Analyst ratings (Buy, Hold, Sell) for Sanofi stock.
Sanofi Financial Performance
Revenues and expenses
Sanofi Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sanofi stock?
Sanofi (SAN) has a market cap of €103B as of September 02, 2025.
What is the P/E ratio for Sanofi stock?
The price to earnings (P/E) ratio for Sanofi (SAN) stock is 11.46 as of September 02, 2025.
Does Sanofi stock pay dividends?
Yes, the Sanofi (SAN) stock pays dividends to shareholders. As of September 02, 2025, the dividend rate is €3.92 and the yield is 4.65%. Sanofi has a payout ratio of 52.29% on a trailing twelve-month basis.
When is the next Sanofi dividend payment date?
The next Sanofi (SAN) dividend payment date is unconfirmed.
What is the beta indicator for Sanofi?
Sanofi (SAN) has a beta rating of 0.41. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.